Are GLP-1 Medications Still in Shortage in 2026?
Last updated: January 2026
Quick Answer
Brand-name shortages have improved but spot shortages still occur. Compounded versions are generally not affected by brand-name supply issues.
Are GLP-1 Medications Still in Shortage in 2026
Brand-name shortages have improved but spot shortages still occur. Compounded versions are generally not affected by brand-name supply issues.
Understanding how GLP-1 medications work, their differences, and what to expect during treatment helps you make informed decisions about your weight loss journey. These medications represent a breakthrough in obesity treatment, with clinical trial results that far exceed previous weight loss interventions.
Key Facts
- GLP-1 medications are FDA-approved and backed by large-scale clinical trials
- Semaglutide and tirzepatide are the two most commonly prescribed GLP-1 medications for weight loss
- Both are administered as weekly subcutaneous injections using easy-to-use pen devices
- Treatment starts at a low dose and gradually increases over 16-20 weeks
- Most patients experience significant appetite reduction within the first week
Choosing the Right Medication
Your healthcare provider will help determine which GLP-1 medication is best for your specific situation based on your health conditions, weight loss goals, insurance coverage, and budget. Both semaglutide and tirzepatide are highly effective options.
Related Questions
Is Compounded GLP-1 Safe?
Compounded GLP-1 from FDA-registered 503B outsourcing facilities is considered safe. Verify the pharmacy is licensed and PCAB-accredited.
What Is the Best GLP-1 Medication for Weight Loss in 2026?
Tirzepatide (Zepbound/Mounjaro) produces the highest average weight loss at 20-22%, followed by semaglutide (Wegovy) at 15%.